Status: Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Participants needed: 100
Trial details
Age: 18-95Biological sex: AllType: InterventionalSponsor: LimFlow, Inc.Updated: Apr 16, 2026Locations: 30
Eligibility criteria
Subject must be ≥ 18 and ≤ 95 years of age [+14]
Concomitant hepatic insufficiency, thrombophlebitis in the target limb, or non-t... [+14]